Literature DB >> 27191998

Can new treatment developments combat resistance in malaria?

Nicholas J White1.   

Abstract

Entities:  

Keywords:  Malaria; P. falciparum; artefenomel; artemisinin; arterolane; cipargamin; resistance

Year:  2016        PMID： 27191998     DOI： 10.1080/14656566.2016.1187134

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  17 in total

1.  Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.

Authors:  Joy C Ebenebe; Godwin Ntadom; Jose Ambe; Robinson Wammanda; Nma Jiya; Finomo Finomo; George Emechebe; Olugbenga Mokuolu; Kazeem Akano; Chimere Agomo; Onikepe A Folarin; Stephen Oguche; Francis Useh; Wellington Oyibo; Temitope Aderoyeje; Mohammed Abdulkadir; Nnenna M Ezeigwe; Christian Happi; Akintunde Sowunmi
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 2.345

2.  Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.

Authors:  Sri Riyati Sugiarto; Brioni R Moore; Julie Makani; Timothy M E Davis
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

3.  Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea.

Authors:  Harparkash Kaur; Elizabeth Louise Allan; Ibrahim Mamadu; Zoe Hall; Michael D Green; Isabel Swamidos; Prabha Dwivedi; Maria Julia Culzoni; Facundo M Fernandez; Guillermo Garcia; Dianna Hergott; Feliciano Monti
Journal:  BMJ Glob Health       Date:  2017-10-15

Review 4.  Combating multidrug-resistant Plasmodium falciparum malaria.

Authors:  Aung Myint Thu; Aung Pyae Phyo; Jordi Landier; Daniel M Parker; François H Nosten
Journal:  FEBS J       Date:  2017-06-30       Impact factor: 5.542

5.  Challenges to replace ACT as first-line drug.

Authors:  Aung Pyae Phyo; Lorenz von Seidlein
Journal:  Malar J       Date:  2017-07-24       Impact factor: 2.979

6.  The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.

Authors:  Mallika Imwong; Kanokon Suwannasin; Chanon Kunasol; Kreepol Sutawong; Mayfong Mayxay; Huy Rekol; Frank M Smithuis; Tin Maung Hlaing; Kyaw M Tun; Rob W van der Pluijm; Rupam Tripura; Olivo Miotto; Didier Menard; Mehul Dhorda; Nicholas P J Day; Nicholas J White; Arjen M Dondorp
Journal:  Lancet Infect Dis       Date:  2017-02-02       Impact factor: 25.071

7.  Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.

Authors:  Angana Mukherjee; Selina Bopp; Pamela Magistrado; Wesley Wong; Rachel Daniels; Allison Demas; Stephen Schaffner; Chanaki Amaratunga; Pharath Lim; Mehul Dhorda; Olivo Miotto; Charles Woodrow; Elizabeth A Ashley; Arjen M Dondorp; Nicholas J White; Dyann Wirth; Rick Fairhurst; Sarah K Volkman
Journal:  Malar J       Date:  2017-05-12       Impact factor: 2.979

8.  Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.

Authors:  Ngo Viet Thanh; Nguyen Thuy-Nhien; Nguyen Thi Kim Tuyen; Nguyen Thanh Tong; Nguyen Thuy Nha-Ca; Le Thanh Dong; Huynh Hong Quang; Jeremy Farrar; Guy Thwaites; Nicholas J White; Marcel Wolbers; Tran Tinh Hien
Journal:  Malar J       Date:  2017-01-13       Impact factor: 2.979

9.  Malaria incidence in Myanmar 2005-2014: steady but fragile progress towards elimination.

Authors:  Thet Thet Mu; Aye Aye Sein; Tint Tint Kyi; Myo Min; Ne Myo Aung; Nicholas M Anstey; Myat Phone Kyaw; Chit Soe; Mar Mar Kyi; Josh Hanson
Journal:  Malar J       Date:  2016-10-18       Impact factor: 2.979

10.  Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.

Authors:  Henriette Bosson-Vanga; Jean-François Franetich; Valérie Soulard; Daniel Sossau; Maurel Tefit; Bocar Kane; Jean-Christophe Vaillant; Steffen Borrmann; Olaf Müller; Nathalie Dereuddre-Bosquet; Roger Le Grand; Olivier Silvie; Dominique Mazier
Journal:  Malar J       Date:  2018-04-03       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.